Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2022-04-01
Saila:Thrombosis Journal
Gaiak:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Sarrera elektronikoa:https://doi.org/10.1186/s12959-022-00380-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak